Logo image of COO

COOPER COS INC/THE (COO) Stock Fundamental Analysis

NASDAQ:COO - Nasdaq - US2166485019 - Common Stock - Currency: USD

71.16  +0.02 (+0.03%)

After market: 71.16 0 (0%)

Fundamental Rating

5

COO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. While COO has a great profitability rating, there are some minor concerns on its financial health. COO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year COO was profitable.
COO had a positive operating cash flow in the past year.
Each year in the past 5 years COO has been profitable.
COO had a positive operating cash flow in each of the past 5 years.
COO Yearly Net Income VS EBIT VS OCF VS FCFCOO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

COO has a Return On Assets of 3.34%. This is in the better half of the industry: COO outperforms 79.14% of its industry peers.
COO has a Return On Equity of 5.00%. This is in the better half of the industry: COO outperforms 79.14% of its industry peers.
COO's Return On Invested Capital of 4.58% is fine compared to the rest of the industry. COO outperforms 77.54% of its industry peers.
COO had an Average Return On Invested Capital over the past 3 years of 3.86%. This is below the industry average of 7.89%.
The 3 year average ROIC (3.86%) for COO is below the current ROIC(4.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.34%
ROE 5%
ROIC 4.58%
ROA(3y)3.02%
ROA(5y)8.65%
ROE(3y)4.71%
ROE(5y)12.56%
ROIC(3y)3.86%
ROIC(5y)3.93%
COO Yearly ROA, ROE, ROICCOO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

The Profit Margin of COO (10.39%) is better than 85.03% of its industry peers.
In the last couple of years the Profit Margin of COO has declined.
COO's Operating Margin of 19.00% is amongst the best of the industry. COO outperforms 91.98% of its industry peers.
COO's Operating Margin has declined in the last couple of years.
COO has a better Gross Margin (67.20%) than 73.26% of its industry peers.
In the last couple of years the Gross Margin of COO has remained more or less at the same level.
Industry RankSector Rank
OM 19%
PM (TTM) 10.39%
GM 67.2%
OM growth 3Y0.82%
OM growth 5Y-2.83%
PM growth 3Y-53.59%
PM growth 5Y-10.55%
GM growth 3Y-0.14%
GM growth 5Y0.13%
COO Yearly Profit, Operating, Gross MarginsCOO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

5

2. Health

2.1 Basic Checks

COO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, COO has more shares outstanding
COO has less shares outstanding than it did 5 years ago.
COO has a better debt/assets ratio than last year.
COO Yearly Shares OutstandingCOO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
COO Yearly Total Debt VS Total AssetsCOO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 3.54 indicates that COO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.54, COO is in the better half of the industry, outperforming 72.19% of the companies in the same industry.
The Debt to FCF ratio of COO is 7.07, which is on the high side as it means it would take COO, 7.07 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of COO (7.07) is better than 77.54% of its industry peers.
COO has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.31, COO perfoms like the industry average, outperforming 47.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 7.07
Altman-Z 3.54
ROIC/WACC0.56
WACC8.19%
COO Yearly LT Debt VS Equity VS FCFCOO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.10 indicates that COO has no problem at all paying its short term obligations.
COO's Current ratio of 2.10 is on the low side compared to the rest of the industry. COO is outperformed by 63.64% of its industry peers.
COO has a Quick Ratio of 1.23. This is a normal value and indicates that COO is financially healthy and should not expect problems in meeting its short term obligations.
COO's Quick ratio of 1.23 is on the low side compared to the rest of the industry. COO is outperformed by 71.66% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.23
COO Yearly Current Assets VS Current LiabilitesCOO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

COO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.95%, which is quite good.
Measured over the past 5 years, COO shows a small growth in Earnings Per Share. The EPS has been growing by 3.69% on average per year.
The Revenue has been growing slightly by 6.88% in the past year.
Measured over the past years, COO shows a small growth in Revenue. The Revenue has been growing by 7.98% on average per year.
EPS 1Y (TTM)13.95%
EPS 3Y3.78%
EPS 5Y3.69%
EPS Q2Q%12.94%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y10.05%
Revenue growth 5Y7.98%
Sales Q2Q%6.33%

3.2 Future

Based on estimates for the next years, COO will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.51% on average per year.
The Revenue is expected to grow by 5.84% on average over the next years.
EPS Next Y11.1%
EPS Next 2Y9.77%
EPS Next 3Y9.8%
EPS Next 5Y8.51%
Revenue Next Year5.5%
Revenue Next 2Y5.97%
Revenue Next 3Y6.01%
Revenue Next 5Y5.84%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COO Yearly Revenue VS EstimatesCOO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
COO Yearly EPS VS EstimatesCOO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.34, COO is valued on the expensive side.
Based on the Price/Earnings ratio, COO is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
COO is valuated rather cheaply when we compare the Price/Earnings ratio to 27.15, which is the current average of the S&P500 Index.
COO is valuated correctly with a Price/Forward Earnings ratio of 15.96.
Based on the Price/Forward Earnings ratio, COO is valued cheaply inside the industry as 81.28% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.60, COO is valued a bit cheaper.
Industry RankSector Rank
PE 18.34
Fwd PE 15.96
COO Price Earnings VS Forward Price EarningsCOO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

79.14% of the companies in the same industry are more expensive than COO, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COO indicates a somewhat cheap valuation: COO is cheaper than 78.61% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 38.89
EV/EBITDA 14.84
COO Per share dataCOO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
COO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.65
PEG (5Y)4.98
EPS Next 2Y9.77%
EPS Next 3Y9.8%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.02%, COO is not a good candidate for dividend investing.
COO's Dividend Yield is rather good when compared to the industry average which is at 1.82. COO pays more dividend than 89.84% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, COO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.02%

5.2 History

COO has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
COO Yearly Dividends per shareCOO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.01 0.01 0.02

5.3 Sustainability

DP0%
EPS Next 2Y9.77%
EPS Next 3Y9.8%
COO Yearly Income VS Free CF VS DividendCOO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

COOPER COS INC/THE

NASDAQ:COO (6/30/2025, 8:00:01 PM)

After market: 71.16 0 (0%)

71.16

+0.02 (+0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners101.9%
Inst Owner Change0.75%
Ins Owners0.59%
Ins Owner Change12.84%
Market Cap14.23B
Analysts78.33
Price Target97.4 (36.87%)
Short Float %2.54%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 0.02%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.13%
Min EPS beat(2)-0.21%
Max EPS beat(2)2.46%
EPS beat(4)3
Avg EPS beat(4)2.45%
Min EPS beat(4)-0.21%
Max EPS beat(4)4.45%
EPS beat(8)5
Avg EPS beat(8)2.14%
EPS beat(12)7
Avg EPS beat(12)0.82%
EPS beat(16)9
Avg EPS beat(16)0.35%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.27%
Revenue beat(4)0
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)-0.27%
Revenue beat(8)2
Avg Revenue beat(8)-0.51%
Revenue beat(12)6
Avg Revenue beat(12)-0.1%
Revenue beat(16)10
Avg Revenue beat(16)0.5%
PT rev (1m)-10.44%
PT rev (3m)-11.88%
EPS NQ rev (1m)1.15%
EPS NQ rev (3m)1.15%
EPS NY rev (1m)2.1%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-0.56%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 18.34
Fwd PE 15.96
P/S 3.57
P/FCF 38.89
P/OCF 18.67
P/B 1.72
P/tB 5.21
EV/EBITDA 14.84
EPS(TTM)3.88
EY5.45%
EPS(NY)4.46
Fwd EY6.27%
FCF(TTM)1.83
FCFY2.57%
OCF(TTM)3.81
OCFY5.36%
SpS19.94
BVpS41.44
TBVpS13.65
PEG (NY)1.65
PEG (5Y)4.98
Profitability
Industry RankSector Rank
ROA 3.34%
ROE 5%
ROCE 6.65%
ROIC 4.58%
ROICexc 4.63%
ROICexgc 9.08%
OM 19%
PM (TTM) 10.39%
GM 67.2%
FCFM 9.17%
ROA(3y)3.02%
ROA(5y)8.65%
ROE(3y)4.71%
ROE(5y)12.56%
ROIC(3y)3.86%
ROIC(5y)3.93%
ROICexc(3y)3.91%
ROICexc(5y)3.98%
ROICexgc(3y)7.96%
ROICexgc(5y)8.62%
ROCE(3y)5.65%
ROCE(5y)5.73%
ROICexcg growth 3Y7.03%
ROICexcg growth 5Y-21.56%
ROICexc growth 3Y2.56%
ROICexc growth 5Y-10.24%
OM growth 3Y0.82%
OM growth 5Y-2.83%
PM growth 3Y-53.59%
PM growth 5Y-10.55%
GM growth 3Y-0.14%
GM growth 5Y0.13%
F-Score9
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 7.07
Debt/EBITDA 2.3
Cap/Depr 109.05%
Cap/Sales 9.94%
Interest Coverage 250
Cash Conversion 67.99%
Profit Quality 88.34%
Current Ratio 2.1
Quick Ratio 1.23
Altman-Z 3.54
F-Score9
WACC8.19%
ROIC/WACC0.56
Cap/Depr(3y)96.32%
Cap/Depr(5y)93.28%
Cap/Sales(3y)9.68%
Cap/Sales(5y)9.83%
Profit Quality(3y)87.75%
Profit Quality(5y)70.99%
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y3.78%
EPS 5Y3.69%
EPS Q2Q%12.94%
EPS Next Y11.1%
EPS Next 2Y9.77%
EPS Next 3Y9.8%
EPS Next 5Y8.51%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y10.05%
Revenue growth 5Y7.98%
Sales Q2Q%6.33%
Revenue Next Year5.5%
Revenue Next 2Y5.97%
Revenue Next 3Y6.01%
Revenue Next 5Y5.84%
EBIT growth 1Y25.84%
EBIT growth 3Y10.95%
EBIT growth 5Y4.93%
EBIT Next Year27.65%
EBIT Next 3Y15.28%
EBIT Next 5Y12.64%
FCF growth 1Y-5.53%
FCF growth 3Y-18.09%
FCF growth 5Y-7.31%
OCF growth 1Y11.23%
OCF growth 3Y-1.34%
OCF growth 5Y-0.11%